Consulta nuestras publicaciones
Recursos
Descubre la contribución de OWL Metabolomics al conocimiento científico en nuestra sección de Recursos. Te invitamos a consultar las publicaciones en las que hemos participado, que ofrecen perspectivas clave sobre diferentes áreas terapéuticas. Nuestra biblioteca está aquí para ayudarle en tus necesidades de investigación. Te invitamos a explorar nuestras contribuciones con los recursos que ponemos a tu disposición. Utiliza los filtros para encontrar información por año de publicación, área terapéutica y/o enfermedad.
Mid-term Effects of Bariatric Surgery on Metabolic Dysfunction-Associated Fatty Liver Disease Remission and Predictive Factors: A Prospective Study with a Focus on Non-invasive Diagnosis
Obesity Surgery 2024;34:841-9
/ 2024
Área: Gastroenterology / Hepatology
Patología: MASLD/MASH
Área: Gastroenterology / Hepatology
Patología: MASLD/MASH
Caenorhabditis elegans RAC1/ced-10 mutants as a new animal model to study very early stages of Parkinson’s disease
Prog Neurobiol 2024;234:102572
/ 2024
Área: Neuroscience
Patología: Parkinson’s Disease
Área: Neuroscience
Patología: Parkinson’s Disease
Dietary ω3 Fatty Acids and Phytosterols in the Modulation of the HDL Lipidome: A Longitudinal Crossover Clinical Study.
Nutrients 2023;15(16):3637.
/ 2023
Área: Cardiology / Cardiovascular
Patología: Cardiovascular disease
Área: Cardiology / Cardiovascular
Patología: Cardiovascular disease
Impaired hepatic VLDL secretion promotes tumorigenesis and is accelerated with Fabp1 deletion
Am J Pathol (in press).
/ 2024
Área: Oncology and Gastroenterology / Hepatology
Patología: MASLD/MASH and Hepatocellular carcinoma
Área: Oncology and Gastroenterology / Hepatology
Patología: MASLD/MASH and Hepatocellular carcinoma
Lipidomics and biodistribution of extracellular vesicles-secreted by hepatocytes from Zucker lean and fatty rats
J of Extracellular Bio 2024;3:e140
/ 2024
Área: Metabolomics
Patología: Obesity
Área: Metabolomics
Patología: Obesity
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study.
Hepatology 2023;78(1):258-71
/ 2023
Área: Gastroenterology / Hepatology
Patología: MASLD/MASH
Área: Gastroenterology / Hepatology
Patología: MASLD/MASH
Serum identification of At-Risk MASH: The Metabolomics-Advanced steatohepatitis fibrosis score (MASEF).
Hepatology 2023;79(1):135-148.
/ 2024
Área: Gastroenterology / Hepatology
Patología: MASLD/MASH
Área: Gastroenterology / Hepatology
Patología: MASLD/MASH
Metabolomic signature and molecular profile of normal and degenerated human intervertebral disc cells
The Spine Journal 2023;23(10):1549-62
/ 2023
Área: Neuroscience
Patología: Intervertebral disc degeneration
Área: Neuroscience
Patología: Intervertebral disc degeneration
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant. data meta-analysis
Lancet Gastroenterol Hepatol 2023; 8(8):704-13.
/ 2023
Área: Gastroenterology / Hepatology
Patología: MASLD/MASH
Área: Gastroenterology / Hepatology
Patología: MASLD/MASH
miR-21-5p promotes NASH-related hepatocarcinogenesis.
Liver International 2023;43(3):2256-74
/ 2023
Área: Oncology and Gastroenterology / Hepatology
Patología: MASLD/MASH and Hepatocellular carcinoma
Área: Oncology and Gastroenterology / Hepatology
Patología: MASLD/MASH and Hepatocellular carcinoma
Serum lipidome unravels a diagnostic potential in bile acid diarrhoea.
Lewinska M, et al. Gut 2023;72(9):1698-708.
/ 2023
Área: Gastroenterology / Hepatology
Patología: Bile acid diarrhoea
Área: Gastroenterology / Hepatology
Patología: Bile acid diarrhoea
Impaired Function of Solute Carrier Family 19 Leads to Low Folate Levels and Lipid Droplet Accumulation in Hepatocytes.
Biomedicines 2023;11(2):337.
/ 2023
Área: Gastroenterology / Hepatology
Patología: MASLD/MASH
Área: Gastroenterology / Hepatology
Patología: MASLD/MASH
